US warns of genetic risk with epilepsy drugs
This article was originally published in Scrip
Executive Summary
Patients of Asian ancestry may be genetically predisposed to experience Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis caused by the epilepsy drugs phenytoin and fosphenytoin, the US FDAsays.